In this episode, clinicians and a parent advocate explore what EB research and clinical trials mean for patients and families. Pediatric dermatologist Lara Wine Lee, MD, PhD, and Deana Calhoun, whose daughter Cooper lives with recessive dystrophic epidermolysis bullosa (RDEB), discuss the research pipeline, treatment studies, placebo-controlled trials, eligibility, informed consent and assent, and the practical realities of participation. Their conversation highlights the importance of clear communication, patient-centered trial design, and including children and families in decisions about research and care.
For a complete list of guest disclosures, please click here.
Special thanks to BioMendics, Castle Creek Biosciences, Chiesi, and Krystal Biotech for their support of the 2026 EB Educational Series. PeDRA is solely responsible for all program content and the selection of all presenters, authors, moderators, and faculty.



